Perioperative durvalumab has “the potential to transform the standard of care” for patients with muscle-invasive bladder ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the completion of a study ...

“We are disappointed in the ADJUVANT BR.31 results ... NIAGARA compared Imfinzi plus chemo to chemo alone in muscle-invasive bladder cancer (MIBC) patients scheduled for a cystectomy to ...

MSD presented positive data for its PD-1 drug Keytruda (pembrolizumab) for adjuvant ... of Barts Cancer Centre in London, UK, pointed out that neoadjuvant chemotherapy and bladder removal have ...

CALGB (Alliance)/SWOG 80702 evaluated the benefit of adding celecoxib to FOLFOX in postoperative treatment of stage III colorectal cancer (CRC ... were randomized to receive standard-of-care adjuvant ...

(UroToday.com) The 2024 South Central AUA annual meeting included a session on bladder cancer, featuring a presentation by Dr. Gal Saffati discussing a systematic review and meta-analysis of early ...

Chemotherapy can also be used as an adjuvant therapy with irradiation or surgery in patients with breast cancer, prostate cancer ... and maintenance of bowel and bladder function, and provision ...

(UroToday.com) The 2024 European Association of Urology (EAU) annual meeting featured a game changing session on prime time for adjuvant treatment in locally advanced bladder cancer ... neoadjuvant ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Adjuvant durvalumab did not improve disease-free survival in patients with early-stage non-small cell lung cancer in the phase 3 BR.31 trial.

There are about 80,000 new cases of bladder cancer every year in the US alone ... This research has determined that ...

Radical cystectomy continues to be the treatment of choice for muscle-invasive bladder cancer. However ... Although, some studies with adjuvant and neoadjuvant radiotherapy showed improved ...